CANADA LIFE ASSURANCE Co - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 127 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$34,000
-10.5%
10,0000.0%0.00%
Q2 2018$38,000
-7.3%
10,0000.0%0.00%
Q1 2018$41,000
-10.9%
10,0000.0%0.00%
Q4 2017$46,000
-35.2%
10,0000.0%0.00%
Q3 2017$71,000
-1.4%
10,0000.0%0.00%
Q2 2017$72,000
+18.0%
10,0000.0%0.00%
Q1 2017$61,000
+3.4%
10,0000.0%0.00%
Q4 2016$59,000
-44.3%
10,000
-50.0%
0.00%
Q3 2016$106,000
+60.6%
20,000
+100.0%
0.00%
Q2 2016$66,000
+43.5%
10,0000.0%0.00%
Q1 2016$46,000
-9.8%
10,0000.0%0.00%
Q4 2015$51,000
+45.7%
10,0000.0%0.00%
Q3 2015$35,000
-65.0%
10,0000.0%0.00%
Q2 2015$100,000
-21.3%
10,0000.0%0.00%
Q1 2015$127,000
-9.9%
10,0000.0%0.00%
Q4 2014$141,000
+2.2%
10,0000.0%0.00%
Q3 2014$138,000
-9.8%
10,0000.0%0.00%
-100.0%
Q2 2014$153,00010,0000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$16,990,00016.50%
VHCP Management, LLC 1,000,273$12,954,0006.97%
Cormorant Asset Management, LP 1,700,000$22,015,0006.39%
HARVEY CAPITAL MANAGEMENT INC 890,500$11,531,0004.76%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 859,672$11,133,0002.50%
Rhenman & Partners Asset Management AB 400,000$5,180,0002.03%
SECTORAL ASSET MANAGEMENT INC 2,758,950$35,728,0001.54%
NORTHPOINTE CAPITAL LLC 1,289,711$16,701,0001.47%
Knoll Capital Management, LLC 200,000$2,592,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,483,260$19,208,0001.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders